Search - tctmd.com

Displaying 21 - 40 of 165

Sort: Relevancy | Date

Presentation TCT 2017

Case #1: The European Bifurcation Club Position on OCT in LMCA Bifurcation Stenting

Presenter: Evald H. Christiansen, Niels R. Holm, Jens Flensted Lassen

October 31, 2017

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

Presentation TCT 2017

TCT 48: Potential Intraplaque Hemorrhage Pattern Assessed by Combined Intravascular Ultrasound and Optical Coherence Tomography

Presenter: John McB. Hodgson, Akiko Maehara, Tetsumin Lee, MD

October 31, 2017

Presentation TCT 2017

TCT 47: Morphological Difference of Culprit Lesions by Age and Gender Assessed by Optical Coherence Tomography

Presenter: John McB. Hodgson, Akiko Maehara, Mitsuaki Matsumura, MD

October 31, 2017

Presentation TCT 2017

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

Presenter: Thomas F. Luscher, Ziad A. Ali

October 31, 2017

Presentation TCT 2017

TCT 45: IV-OCT Virtual Histology: Automatic Identification of Human

Presenter: John McB. Hodgson, Akiko Maehara, Taylor Hoyt, MD

October 31, 2017

Presentation TCT 2017

FAVOR II Europe Japan: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Jelmer Westra

October 31, 2017

Presentation TCT 2017

TCT 28: A New Optical Coherence Tomography-Based Calcium Scoring System to Predict Stent Underexpansion

Presenter: Ehrin J. Armstrong, Gert Richardt, Akiko Fujino, MD

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

FAVOR II China: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Bo Xu

October 31, 2017

Presentation TCT 2017

REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions

Presenter: Robert-Jan van Geuns, Kambis Mashayekhi

October 31, 2017

Presentation TCT 2017

TCT 42: LONG-TERM CONSEQUENCES of Optical coherence tomography FINDINGS DURING PERCUTANEOUS CORONARY INTERVENTION: The Centro per la Lotta contro lInfarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE Study

Presenter: Ulf Landmesser, Bernhard Witzenbichler, Enrico Romagnoli, MD

October 31, 2017

Presentation TCT 2017

CrossBoss First: A Randomized Trial of Antegrade Dissection and Re-entry vs Standard Wire Escalation for Crossing Coronary Artery Chronic Total Occlusions

Presenter: Robert-Jan van Geuns, Emmanouil S. Brilakis

October 31, 2017

Presentation TCT 2017

TCT 25: Insights Into The Mechanisms Of Action Of The Rotational Atherectomy: An Oct Study

Presenter: Ehrin J. Armstrong, Gert Richardt, Riadh Rihani, MD

October 31, 2017

Presentation TCT 2017

ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

Advertisement

Case #1: The European Bifurcation Club Position on OCT in LMCA Bifurcation Stenting

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

TCT 48: Potential Intraplaque Hemorrhage Pattern Assessed by Combined Intravascular Ultrasound and Optical Coherence Tomography

TCT 47: Morphological Difference of Culprit Lesions by Age and Gender Assessed by Optical Coherence Tomography

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

TCT 45: IV-OCT Virtual Histology: Automatic Identification of Human

FAVOR II Europe Japan: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

TCT 28: A New Optical Coherence Tomography-Based Calcium Scoring System to Predict Stent Underexpansion

Long-term Absorb BVS Data Continue to Disappoint

FAVOR II China: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions

TCT 42: LONG-TERM CONSEQUENCES of Optical coherence tomography FINDINGS DURING PERCUTANEOUS CORONARY INTERVENTION: The Centro per la Lotta contro lInfarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE Study

CrossBoss First: A Randomized Trial of Antegrade Dissection and Re-entry vs Standard Wire Escalation for Crossing Coronary Artery Chronic Total Occlusions

TCT 25: Insights Into The Mechanisms Of Action Of The Rotational Atherectomy: An Oct Study

ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Live From Denver: TCT 2017, Day Two

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content